After-Hours Movers 10/25: (OGXI) (AKAM) (VRTX) Higher; (EW) (NUVA) (CMG) (AAPL) Lower (more...)

Oppenheimer Raises Price Target on Capital One Financial (COF) Following 3Q Report

Oppenheimer reiterated an Underperform rating on Capital One Financial (NYSE: COF), and raised the price target to $60.00 (from $59.00), following the company's 3Q earnings report. Reported earnings were $1.92 vs. the consensus of $1.94 on a continuing ops basis. Core revenues were higher and market expense... More

Apple (AAPL) PT Raised to $135 at Brean Capital

Brean Capital analyst Ananda Baruah reiterated a Buy rating and raised its price target on Apple (NASDAQ: AAPL) to $135.00 (from $125.00) following results.

Baruah commented, "AAPL Dec Q guidance suggests that not only are iPhone units continuing to gain strength (as... More

Jefferies Reiterates Buy Following Express Scripts' (ESRX) 3Q

Jefferies reiterated a Buy rating and $88.00 price target on Express Scripts (NASDAQ: ESRX) following the company's 3Q earnings report. EPS of $1.74 was 1c above consensus and was up 21% Y/Y.

Analyst Brian Tanquilut commented, "We're maintaining our Buy on ESRX... More

Jefferies Remains Sidelined on Capital One Financial (COF) Following EPS Beat

Jefferies reiterated a Hold rating and $69.00 price target on Capital One Financial (NYSE: COF) following the company's 3Q earnings report. COF reported EPS of $2.03, ahead of the consensus estimate of $1.94.

Analyst John Hecht commented, "COF reported adjusted 3Q16 EPS of $2.03 versus our estimate... More

Wedbush Raises price Target on NCR Corp. (NCR) Following 3Q; Reiterates Neutral

Wedbush reiterated a Neutral rating on NCR Corp. (NYSE: NCR), and raised the price target to $30.00 (from $25.00), following the company's 3Q earnings report. Revenue of $1.68 billion beat consensus expectations of $1.63 billion. Non-GAAP EPS of $0.87 beat consensus of $0.81 on $0.06 of onetime add backs.... More

Jefferies Reiterates Buy on NuVasive (NUVA) Following 3Q Report

Jefferies reiterated a Buy rating and $72.00 price target on NuVasive (NASDAQ: NUVA) following the company's 3Q earnings report. For the year, the company is now guiding to $952mn in sales (down from $962mn). Components of this include the US capital stocking issue of... More

RBC Capital Raises Price Target on Akamai Technologies (AKAM) to $67 Following Solid 3Q

RBC Capital reported a Sector Perform rating on Akamai Technologies (NASDAQ: AKAM), and raised the price target to $67.00 (from $59.00), following the company's 3Q earnings report. AKAM reported revenues of $584MM, above the Street's estimate $572MM. The beat was driven by stronger than expected results in... More